The unparalleled
potential of AHPSCs™

 

APstem’s revolutionary cell products are developed from a unique class of stem cells called Adult High-Plasticity Stem Cells (AHPSCs™).

AHPSCs™ are unique from other stem cell therapies and safely support the regeneration of all types of tissues. Our proprietary isolation, culturing, and amplification techniques allow AHPSCs™ to circumvent significant obstacles that constrain current stem cell technologies. AHPSCs™ are establishing a new era in cell therapy.

 
 

APstem Therapeutics’ unique,
simple 3-step AHPSC™ stem cell platform:

 
12.png

1. Isolate

Our scientists isolate a unique population of dormant precursor cells from unmobilized adult peripheral blood.

13.png

2. Activate
and Develop

We then activate and expand these precursor cells in our culture platform to generate
one-of-a-kind AHPSCs.

Differentiation Diagram 3.jpg
 
 

AHPSCs™ have high plasticity meaning they can become various cell types from three germ layers for tissue repair and reconstitution. Because of the enormous need, we decided to first focus on treating diabetic ulcers, diabetes, and neurodegenerative diseases with a goal of tackling age-related health challenges in the near future.

 
 
 
 

The remarkable advantages of AHPSCs™ include:

1.jpg

AHPSCs™ are easily obtained from peripheral blood using a simple blood draw from healthy donors.

1.jpg

Outstanding capacity of self-renewal and quick expansion in vitro enabling large-scale manufacture and banking of AHPSCs™.

Isolati.jpg

Efficient targeted differentiation and powerful therapeutic function of AHPSCs™ with the ability to repair numerous types of damaged tissues.

1.jpg

Low immunogenicity allows AHPSCs™ to be an “off-the-shelf” cell product for allogeneic transplant, without tissue matching or immune suppression.

1.jpg

AHPSCs™ promote angiogenesis and reduce inflammation during an accelerated repair process.

Isolati.jpg

No genetic manipulation or modification. AHPSCs™ have been shown to be non-tumorigenic in safety assessments.